Federated Hermes
KYTX icon

Federated Hermes’s Kyverna Therapeutics KYTX Stock Holding History

Federated Hermes’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$179K Hold
20,705
– – ﹤0.01% 1513
2025
Q4 		$195K Buy
20,705
+5,547
+37% +$41.2K ﹤0.01% 1499
2025
Q3 		$90.9K Sell
15,158
-28,842
-66% -$115K ﹤0.01% 1591
2025
Q2 		$135K Buy
44,000
+8,000
+22% +$19.8K ﹤0.01% 1550
2025
Q1 		$69.5K Buy
36,000
+4,000
+13% +$11.8K ﹤0.01% 1607
2024
Q4 		$120K Hold
32,000
– – ﹤0.01% 1554
2024
Q3 		$156K Buy
32,000
+16,000
+100% +$123K ﹤0.01% 1518
2024
Q2 		$120K Buy
+16,000
New +$244K ﹤0.01% 1547

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Federated Hermes's KYTX Position: Q1 2026 in Review

Federated Hermes held its Kyverna Therapeutics (KYTX) position steady in Q1 2026 at 20,705 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

Federated Hermes first reported a position in KYTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $195K in Q4 2025. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Federated Hermes held 20,705 shares of Kyverna Therapeutics worth $179K as of Q1 2026.
  • Federated Hermes left its Kyverna Therapeutics share count unchanged in Q1 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1513 holding.
  • Federated Hermes first reported a position in Kyverna Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Federated Hermes's Kyverna Therapeutics position peaked at $195K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.